InvestorsHub Logo
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: noretreat post# 96220

Monday, 03/30/2015 1:03:06 PM

Monday, March 30, 2015 1:03:06 PM

Post# of 402457

The "half-empty" view is more like..."If K were showing efficacy there would be more focus on it and cohorts would advance more quickly".


My experience is the opposite. If a Phase 1 cancer drug isn't showing efficacy, they rush through it to get to Phase 2 efficacy and optimization, then rush through that to get to Phase 2b in combination. That is when the trial slows to a crawl.

Another GIF in the cat meme:

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News